1. Home
  2. IT vs GH Comparison

IT vs GH Comparison

Compare IT & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gartner Inc.

IT

Gartner Inc.

HOLD

Current Price

$164.16

Market Cap

11.2B

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$85.05

Market Cap

13.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IT
GH
Founded
1979
2011
Country
United States
United States
Employees
40
N/A
Industry
Other Consumer Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.2B
13.3B
IPO Year
2010
2018

Fundamental Metrics

Financial Performance
Metric
IT
GH
Price
$164.16
$85.05
Analyst Decision
Hold
Strong Buy
Analyst Count
10
20
Target Price
$270.44
$117.80
AVG Volume (30 Days)
1.4M
1.6M
Earning Date
05-05-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
6.74
EPS
9.65
N/A
Revenue
$2,021,441,000.00
$982,021,000.00
Revenue This Year
$3.66
$33.40
Revenue Next Year
$5.15
$28.32
P/E Ratio
$16.69
N/A
Revenue Growth
13.30
32.88
52 Week Low
$139.18
$36.36
52 Week High
$451.73
$120.74

Technical Indicators

Market Signals
Indicator
IT
GH
Relative Strength Index (RSI) 48.05 35.88
Support Level $155.50 $82.26
Resistance Level $172.23 $103.16
Average True Range (ATR) 6.32 3.68
MACD 1.79 0.09
Stochastic Oscillator 55.49 23.00

Price Performance

Historical Comparison
IT
GH

About IT Gartner Inc.

Gartner Inc delivers actionable, objective business and technology insights that drive smarter decisions and stronger performance on an organization's mission-critical priorities. It delivers its products and services globally through three reportable segments - Business and Technology Insights, Conferences and Consulting. Insights equips executives and their teams from every Majority function, geography, industry and sector with actionable, objective insights, guidance and tools. Conferences provides executives and teams across an organization the opportunity to learn, share and network. and Consulting serves senior executives technology-driven strategic initiatives leveraging the power of Gartner's actionable, objective insight. The Majority revenue is derived from the Insights segment.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: